Cargando…

Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation

Venous malformations represent a major sector of vascular anomalies. Most cases are asymptomatic or subclinical; however, large extensive lesions can cause severe disability and sometimes mortality. In this report, we present a successful case of sirolimus treatment in managing an extensive venous m...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelbaky, Mohamed Aly, Ragab, Iman Ahmed, AbouZeid, Amr AbdelHamid, Mohammad, Shaimaa Abdelsattar, Dahab, Mohamed Moussa, Elsherbeny, Mohammed, Safaan, Hatem Abdelkader
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738235/
https://www.ncbi.nlm.nih.gov/pubmed/33335826
http://dx.doi.org/10.1055/s-0040-1716895
_version_ 1783623088712187904
author Abdelbaky, Mohamed Aly
Ragab, Iman Ahmed
AbouZeid, Amr AbdelHamid
Mohammad, Shaimaa Abdelsattar
Dahab, Mohamed Moussa
Elsherbeny, Mohammed
Safaan, Hatem Abdelkader
author_facet Abdelbaky, Mohamed Aly
Ragab, Iman Ahmed
AbouZeid, Amr AbdelHamid
Mohammad, Shaimaa Abdelsattar
Dahab, Mohamed Moussa
Elsherbeny, Mohammed
Safaan, Hatem Abdelkader
author_sort Abdelbaky, Mohamed Aly
collection PubMed
description Venous malformations represent a major sector of vascular anomalies. Most cases are asymptomatic or subclinical; however, large extensive lesions can cause severe disability and sometimes mortality. In this report, we present a successful case of sirolimus treatment in managing an extensive venous malformation in the pelvis of a 21-month-old boy who presented with life-threatening complications. With a history dating since the day 2 of life, the patient suffered from chronic bleeding due to scrotal skin ulcerations, in addition to recurrent attacks of severe bleeding per rectum necessitating hospital admission and blood transfusion (three attacks since the age of 7 months). Pelvic magnetic resonance image showed the typical findings of extensive venous malformation involving the pelvis, perineum, scrotum, and extending to the gluteal region. The lesion was seen totally encasing the anorectum with marked thickening of their walls almost occluding their lumen. Oral sirolimus (2 mg/m (2) ) was started with a target blood trough level of 5 to 10 ng/mL. Over a follow-up period of 5 months, there was obvious clinical improvement that included healing of skin lesions (scrotal ulcer) with complete re-epithelialization, absence of bleeding per rectum with improvement of constipation, and rise of hemoglobin level from 7.5 to 11.5 g/dL.
format Online
Article
Text
id pubmed-7738235
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-77382352020-12-16 Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation Abdelbaky, Mohamed Aly Ragab, Iman Ahmed AbouZeid, Amr AbdelHamid Mohammad, Shaimaa Abdelsattar Dahab, Mohamed Moussa Elsherbeny, Mohammed Safaan, Hatem Abdelkader European J Pediatr Surg Rep Venous malformations represent a major sector of vascular anomalies. Most cases are asymptomatic or subclinical; however, large extensive lesions can cause severe disability and sometimes mortality. In this report, we present a successful case of sirolimus treatment in managing an extensive venous malformation in the pelvis of a 21-month-old boy who presented with life-threatening complications. With a history dating since the day 2 of life, the patient suffered from chronic bleeding due to scrotal skin ulcerations, in addition to recurrent attacks of severe bleeding per rectum necessitating hospital admission and blood transfusion (three attacks since the age of 7 months). Pelvic magnetic resonance image showed the typical findings of extensive venous malformation involving the pelvis, perineum, scrotum, and extending to the gluteal region. The lesion was seen totally encasing the anorectum with marked thickening of their walls almost occluding their lumen. Oral sirolimus (2 mg/m (2) ) was started with a target blood trough level of 5 to 10 ng/mL. Over a follow-up period of 5 months, there was obvious clinical improvement that included healing of skin lesions (scrotal ulcer) with complete re-epithelialization, absence of bleeding per rectum with improvement of constipation, and rise of hemoglobin level from 7.5 to 11.5 g/dL. Georg Thieme Verlag KG 2020-01 2020-12-15 /pmc/articles/PMC7738235/ /pubmed/33335826 http://dx.doi.org/10.1055/s-0040-1716895 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ) https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abdelbaky, Mohamed Aly
Ragab, Iman Ahmed
AbouZeid, Amr AbdelHamid
Mohammad, Shaimaa Abdelsattar
Dahab, Mohamed Moussa
Elsherbeny, Mohammed
Safaan, Hatem Abdelkader
Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title_full Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title_fullStr Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title_full_unstemmed Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title_short Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
title_sort sirolimus: a rescue drug to control complications of extensive venous malformation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738235/
https://www.ncbi.nlm.nih.gov/pubmed/33335826
http://dx.doi.org/10.1055/s-0040-1716895
work_keys_str_mv AT abdelbakymohamedaly sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT ragabimanahmed sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT abouzeidamrabdelhamid sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT mohammadshaimaaabdelsattar sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT dahabmohamedmoussa sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT elsherbenymohammed sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation
AT safaanhatemabdelkader sirolimusarescuedrugtocontrolcomplicationsofextensivevenousmalformation